EUVIMEDEUVIMED entdecken
Crossref

CD9-positive Exosomes Derived from Cancer-associated Fibroblasts Might Inhibit the Proliferation of Malignant Melanoma Cells

Naho Fujii, Masakazu Yashiro, Takaharu Hatano, Heishiro Fujikawa, Hisashi Motomura

Anticancer Research · 2023

DOI: 10.21873/anticanres.16130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Naho Fujii und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Reconstructive Surgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan. Hauptthemen laut MEDLINE: Exosomes, Melanoma. Die Arbeit wurde bisher 21-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Exosomes secreted by various cells in the tumour microenvironment have been reported to be mediators of intercellular communication that play an important role in cancer progression. In this study, we aimed to investigate the effects of exosomes derived from cancer-associated fibroblasts (CAFs) on the proliferation of malignant melanoma (MM) cells and evaluated their clinicopathological significance. MATERIALS AND METHODS: Three malignant melanoma cell lines, A375, MMAc, and COLO679, and three CAFs established from malignant melanomas at stages 1a, 2b, and 3b, were used. The expression of CD9, CD63, and CD81 in CAF-derived exosomes was examined using western blotting. The effect of exosomes on the proliferative potential of cancer cells was analysed using cell counting and MTT assays. The expression of CD9, CD63, and CD81 was also immunohistochemically analysed in 90 malignant melanoma specimens. RESULTS: CAF-derived exosomes were positive for CD9 and CD63 and remarkably inhibited the proliferative capacity of A375 and MMAc cells. The five-year disease-free survival was significantly better in patients with CAF-derived CD9-positive exosomes than in CD9-negative patients. CONCLUSION: CAF-derived exosomes, especially CD9-positive exosomes, have an inhibitory effect on the proliferation of malignant melanoma cells. These findings suggest that CD9 expression in CAFs is a promising prognostic marker for patients with malignant melanoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesMelanomaHumansCancer-Associated FibroblastsCell ProliferationFibroblastsTetraspanin 29Tumor MicroenvironmentBiomarkers, TumorPrognosisCutaneous Malignant Melanoma

Stichwörter der Autor:innen

CD9Malignant melanomacancer-associated fibroblastsexosomes

Substanzen

CD9 protein, humanTetraspanin 29Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Plastic and Reconstructive Surgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
  • Molecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan; i21496f@omu.ac.jp.
  • Cancer Center for Translational Research, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.

Zitieren

APA

Fujii, N., Yashiro, M., Hatano, T., Fujikawa, H., & Motomura, H. (2023). CD9-positive Exosomes Derived from Cancer-associated Fibroblasts Might Inhibit the Proliferation of Malignant Melanoma Cells. Anticancer Research. https://doi.org/10.21873/anticanres.16130

Vancouver

Fujii N, Yashiro M, Hatano T, Fujikawa H, Motomura H. CD9-positive Exosomes Derived from Cancer-associated Fibroblasts Might Inhibit the Proliferation of Malignant Melanoma Cells. Anticancer Research. 2023. doi:10.21873/anticanres.16130

BibTeX
@article{Fujii2023,
  author = {Fujii, Naho and Yashiro, Masakazu and Hatano, Takaharu and Fujikawa, Heishiro and Motomura, Hisashi},
  title = {CD9-positive Exosomes Derived from Cancer-associated Fibroblasts Might Inhibit the Proliferation of Malignant Melanoma Cells},
  journal = {Anticancer Research},
  year = {2023},
  doi = {10.21873/anticanres.16130}
}
Kostenlos starten →